53
Participants
Start Date
January 31, 2006
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
Risperidone prolonged release
Risperidone will be administered as intramuscular injection as 25 milligram (mg) every two weeks, from Week 1 to 50, wherein after Week 3, dose may be adjusted up to 50 mg at physician criterion. For first two weeks, previous oral antipsychotic drug will be maintained and the dose will be gradually decreased and will cease at Week 3.
Curitiba
Porto Alegre
Rio de Janeiro
Salvador
São Paulo
Janssen-Cilag Ltd.
INDUSTRY